Randomized, Parallel Group Study to Evaluate the Safety, Pharmacokinetics, and Dose Response of Paltusotine Treatment in Subjects with Carcinoid Syndrome
HEALTHY PARTICIPANTS: No
TYPE: Interventional Study
The purpose of this study is to learn the effects of an experimental oral medication on subjects with carcinoid syndrome. This study will help researchers understand how the medication enters the bloodstream after it is administered, how long it stays in the bloodstream, how it is absorbed, and how long it takes to be cleared from your body, and the symptomatic response of different doses of treatment in subjects with carcinoid syndrome.
Who Can Participate
Participants 18 years old and older with a diagnosis of carcinoid syndrome may be eligible for this study.